Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
11
×
Tags
biotech
11
×
boston blog main
boston top stories
11
×
life sciences
national blog main
san francisco blog main
clinical trials
national top stories
san francisco top stories
eli lilly
indiana blog main
indiana top stories
national
new york blog main
new york top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
cancer immunotherapy
deals
startups
investing
johnson & johnson
medical device
medicare
merck
abbvie
What
companies
11
×
new
bio
drug
roundup
ipo
life
science
week
raised
therapeutics
therapies
approval
biotech
black
diamond
disease
drugs
fda
latest
leading
medicines
momentum
nash
neuro
news
price
research
street
wall
year
abandoning
ago
alzheimer’s
approved
arena’s
arguments
arrival
associated
baggage
Language
unset
Current search:
photo
×
companies
×
biotech
×
" boston top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M